{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:48:34Z","timestamp":1784371714947,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"am","delay-in-days":280,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["2015-16"],"award-info":[{"award-number":["2015-16"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007063","name":"University of Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.actatropica.2019.105109","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T11:05:00Z","timestamp":1563966300000},"page":"105109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["In vitro synergistic interaction of potent 4-aminoquinolines in combination with dihydroartemisinin against chloroquine-resistant Plasmodium falciparum"],"prefix":"10.1016","volume":"199","author":[{"given":"Drishti","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailja","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinkoo D.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2019.105109_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12936-015-0561-2","article-title":"In vitro synergistic effect of fluoroquinolone analogs in combination with artemisinin against Plasmodium falciparum; their antiplasmodial action in rodent malaria model","volume":"14","author":"Agarwal","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2019.105109_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037259","article-title":"Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites","volume":"7","author":"Aguiar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2019.105109_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.44.1.88-96.2000","article-title":"In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum","volume":"44","author":"Akompong","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2019.105109_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2875-13-7","article-title":"Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence","volume":"13","author":"Banek","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2019.105109_bib0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12916-015-0349-9","article-title":"Maximizing antimalarial efficacy and the importance of dosing strategies","volume":"13","author":"Beeson","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.actatropica.2019.105109_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.femsle.2005.09.035","article-title":"Antimalarial drug synergism and antagonism: mechanistic and clinical significance","volume":"253","author":"Bell","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.actatropica.2019.105109_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.indcrop.2017.03.032","article-title":"Not ordinary antimalarial drugs: madagascar plant decoctions potentiating the chloroquine action against Plasmodium parasites","volume":"103","author":"Benelli","year":"2017","journal-title":"Ind. Crops Prod."},{"key":"10.1016\/j.actatropica.2019.105109_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","article-title":"A method for testing for synergy with any number of agents","volume":"137","author":"Berenbaum","year":"1978","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2019.105109_bib0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.09.68","article-title":"Discovery, mechanisms of action and combination therapy of artemisinin","volume":"7","author":"Cui","year":"2009","journal-title":"Expert Rev. Anti. Ther."},{"key":"10.1016\/j.actatropica.2019.105109_bib0050","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actatropica.2019.105109_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0014-5793(94)00921-X","article-title":"Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment)","volume":"352","author":"Egan","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.actatropica.2019.105109_bib0060","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jinorgbio.2007.12.004","article-title":"Recent advances in understanding the mechanism of hemozoin (Malaria pigment) formation","volume":"102","author":"Egan","year":"2007","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.actatropica.2019.105109_bib0065","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2019.105109_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-3156.2003.01180.x","article-title":"CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone\u2013 proguanil against falciparum malaria in Vietnam","volume":"9","author":"Giao","year":"2004","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2019.105109_bib0075","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/AAC.46.5.1510-1515.2002","article-title":"In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against plasmodium falciparum","volume":"46","author":"Gupta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2019.105109_bib0080","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1021\/acs.biochem.8b00959","article-title":"Quantification of free ferriprotoporphyrin IX heme and hemozoin for artemisinin sensitive versus delayed clearance phenotype plasmodium falciparum malarial parasites","volume":"57","author":"Heller","year":"2018","journal-title":"Biochemistry."},{"key":"10.1016\/j.actatropica.2019.105109_bib0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S0031182099006332","article-title":"Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of \u2018dormancy\u2019, a partial cytostatic effect of the drug, and its implication for treatment regimens","volume":"121","author":"Hoshen","year":"2000","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2019.105109_bib0090","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijpara.2017.05.009","article-title":"Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo","volume":"47","author":"Khoury","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2019.105109_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2875-6-125","article-title":"Ensuring sustained ACT production and reliable artemisinin supply","volume":"6","author":"Kindermans","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2019.105109_bib0100","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.lfs.2006.11.008","article-title":"Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update","volume":"80","author":"Kumar","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.actatropica.2019.105109_bib0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpddr.2016.07.001","article-title":"Interactions between 4-aminoquinoline and heme: promising mechanism against Trypanosoma cruzi","volume":"6","author":"Lechuga","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.actatropica.2019.105109_bib0110","first-page":"85","article-title":"Combined antimalarial therapy using artemisinin","volume":"46","author":"Majori","year":"2004","journal-title":"Parassitologia."},{"key":"10.1016\/j.actatropica.2019.105109_bib0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13543784.2019.1560419","article-title":"AQ-13 - an investigational antimalarial drug","volume":"28","author":"Mengue","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.actatropica.2019.105109_bib0120","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S2214-109X(15)00162-X","article-title":"Optimum population-level use of artemisinin combination therapies: a modelling study","volume":"3","author":"Nguyen","year":"2015","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.actatropica.2019.105109_bib0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12936-019-2716-z","article-title":"Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors","volume":"18","author":"Ocan","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2019.105109_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2019.105109_bib0135","article-title":"Artemisinin Conference Final Report","author":"RBM\/UNITAID\/WHO","year":"2011","journal-title":"Hanoi, Vietnam"},{"key":"10.1016\/j.actatropica.2019.105109_bib0140","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1172\/JCI113766","article-title":"A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum","volume":"82","author":"Rosenthal","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actatropica.2019.105109_bib0145","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1128\/AAC.01061-12","article-title":"Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro","volume":"56","author":"S\u00e1enz","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2019.105109_bib0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/1475-2875-11-399","article-title":"Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up","volume":"11","author":"Shretta","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2019.105109_bib0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejmech.2016.06.033","article-title":"4-Aminoquinoline derivatives: synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites","volume":"122","author":"Singh","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2019.105109_bib0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/355167a0","article-title":"Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites","volume":"355","author":"Slater","year":"1992","journal-title":"Nature."},{"key":"10.1016\/j.actatropica.2019.105109_bib0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0020-7519(96)89380-5","article-title":"In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs","volume":"26","author":"Skinner","year":"1996","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2019.105109_bib0170","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2019.105109_bib0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12936-017-1793-0","article-title":"Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey","volume":"16","author":"Thein","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2019.105109_bib0180","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1038\/ncomms10111","article-title":"Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actatropica.2019.105109_bib0185","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","article-title":"Chloroquine-resistant malaria","volume":"184","author":"Wellems","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2019.105109_bib0190","first-page":"389","article-title":"When is enough enough? The need for a robust pipeline of high-quality antimalarials. Medicines for Malaria Venture, Geneva, Switzerland","volume":"9","author":"Wells","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.actatropica.2019.105109_bib0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","article-title":"Malaria parasite clearance","volume":"16","author":"White","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.actatropica.2019.105109_bib0200","series-title":"Status Report on Artemisinin and ACT Resistance","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.actatropica.2019.105109_bib0205","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1550-7408.1983.tb05336.x","article-title":"Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro","volume":"30","author":"Yayon","year":"1983","journal-title":"J. Protozool."},{"key":"10.1016\/j.actatropica.2019.105109_bib0210","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2307\/3281830","article-title":"Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro","volume":"72","author":"Zhang","year":"1986","journal-title":"J. Parasitol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X19301238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X19301238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:19:25Z","timestamp":1762075165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X19301238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":42,"alternative-id":["S0001706X19301238"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2019.105109","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro synergistic interaction of potent 4-aminoquinolines in combination with dihydroartemisinin against chloroquine-resistant Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2019.105109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105109"}}